MATINAS BIOPHARMA HOLDINGS, INC. Leveraged Lease Investment
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Leveraged Lease Investment of $50.00 thousand as of 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Notes
us-gaap:LeveragedLeaseInvestment · last filed 2016-11-14
- 2016-09-30: Leveraged Lease Investment $50.00K.
- 2016-06-30: Leveraged Lease Investment $50.00K.
| Period end | Leveraged Lease Investment |
|---|---|
| 2016-09-30 | $50.00K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $50.00K 10-Q · filed 2016-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |